9,088
Total Claims
$577K
Drug Cost
899
Beneficiaries
$642
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-58%
Cost per patient vs peers
$642 vs $1,524 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 8,150 claims · $116K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Rivaroxaban | 158 | $110K |
| Ticagrelor | 205 | $107K |
| Apixaban | 154 | $95K |
| Dapagliflozin Propanediol | 66 | $42K |
| Sacubitril/Valsartan | 54 | $36K |
| Empagliflozin | 35 | $31K |
| Candesartan/Hydrochlorothiazid | 155 | $23K |
| Candesartan Cilexetil | 172 | $14K |
| Metoprolol Succinate | 1,032 | $12K |
| Evolocumab | 17 | $11K |
| Atorvastatin Calcium | 949 | $8,714 |
| Nifedipine | 264 | $5,172 |
| Losartan Potassium | 411 | $4,526 |
| Isosorbide Mononitrate | 340 | $4,373 |
| Chlorthalidone | 188 | $4,148 |
Prescribing Profile
60
Unique Drugs
$314K
Patient Profile
73
Avg Age
54%
Female
2.15
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About